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Abstract
Background: Profound alterations in immune responses associated with uraemia and exacerbated
by dialysis increase the risk of developing active tuberculosis (TB) in chronic haemodialysis patients
(HDPs). In the current study, was determined the impact of various risk factors on TB
development. Our aim was to identify which HDPs need anti-TB preventive therapy.
Methods:  Prospective study of 272 HDPs admitted, through a 36-month period, to our
institutions. Specific Relative Risk (RR) for TB was estimated, considering age matched subjects
from the general population as reference group. Entering the study all patients were tested with
tuberculin (TST). Using Cox's proportional hazard model the independent effect of various risk
factors associated with TB development was estimated.
Results: History of TB, dialysis efficiency, use of Vitamin D supplements, serum albumin and zinc
levels were not proved to influence significantly the risk for TB, in contrast to: advanced age (>65
years), BMI, diabetes mellitus, tuberculin reactivity, healed TB lesions on chest X-ray and time on
dialysis. Elderly (>70 years old) HDPs (Adjusted RR 25.3, 95%CI 20.4-28.4, P < 0.02), diabetics
(Adj.RR 25.3, 95%CI 17.2-21.1, P < 0.03), underweighted (Adj.RR 72.3, 95%CI 65.2-79.8 P < 0.001),
tuberculin responders (Adj.RR 41.4, 95%CI 37.9-44.8, P < 0.03), HDPs with fibrotic lesions on
chest x-ray (Adj.RR 82.3, 95%CI 51.3-95.5, P < 0.03) and those treated with haemodialysis for < 12
months (Adj.RR 110.0, 95%CI 97.4-135.3, P < 0.001), presented significantly higher specific RR for
TB even after adjusting for the effect of the remaining studied risk factors.
Conclusion: The above mentioned factors have to be considered by the clinicians, evaluating for
TB in HDPs. Positive TST, the existence of predisposing risk factors and/or old TB lesions on chest
X-ray, will guide the diagnosis of latent TB infection and the selection of those HDPs who need
preventive chemoprophylaxis.
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Background
Profound alterations in immune responses associated
with uraemia and exacerbated by dialysis, increase the risk
for developing active tuberculosis (TB) after primary
infection [1]. Frequent hospital contacts, older age and
use of immunosuppressive drugs are additional factors
explaining the higher prevalence of TB in these patients.
Tuberculosis in end-stage renal disease patients on regular
haemodialysis (HDPs) presents a number of diagnostic
challenges. In these patients the symptomatology of TB is
often insidious and non specific, whereas the localization
is often extrapulmonary [2,3]. This makes the disease dif-
ficult to diagnose, delaying the initiation of curative treat-
ment, which is a major determinant of the outcome [2-4].
That is why annual skin testing with tuberculin skin test
(TST) and chemoprophylaxis for all HDPs with a ≥10 mm
response is recommended [5]. However, even today (with
increased dialysis quality and dose) there is a high rate of
anergy reported among HDPs and anergic HDPs are at
increased risk of developing TB [6].
The aim of our study was to identify those HDPs who
would benefit from TB chemoprophylaxis, using a com-
bine approach of risk factors and common screening
methods, like TST and chest X-ray. Specific-risks for TB
were estimated as accordingly to TST results and chest X-
ray findings, as well as history of TB, clinical important
determinants, medication and specific dialysis related fac-
tors like dialysis efficiency and time on dialysis. Associat-
ing the later with the risk for TB we were also able to
identify when the appropriate time to commence TB che-
moprophylaxis in HDPs is.
Methods
Study design
This was a prospective, multi-centre trial conducted over
the course of three years in two chronic haemodialysis
outpatient units affiliated with the University Hospital of
Patras and a third unit in the Nephrology Department of
the General State Hospital in Patras. The study protocol
was approved by the ethical committee of the medical
school of the University of Patras. Patients files were
searched for factors, that might have influenced the risk of
developing TB, like: age, primary renal disease, TB history
(disease, contact, vaccination), time on dialysis (time
elapsed since undergoing haemodialysis), medication
(vitamin D supplements and immunosuppressive drugs
like corticosteroids, cyclophosphamide, calcineurin
inhibitors, azathioprine and mycophenolate mofetil),
and laboratory data like serum albumin and zinc levels.
Dialysis efficiency was measured using equilibrated dialy-
sis dose (Kt/V) and urea reduction ratio (URR). Body Mass
Index (BMI) and serum albumin, were used as markers of
the patients' nutritional status.
Entering the study, participants were evaluated, and active
TB was ruled out by history, physical examination, chest
radiography, and when indicated, bacteriological studies.
Following patients were tested with tuberculin. TB inci-
dence and the subsequent relative risk (RR) for TB was
then determined over a 36 month follow-up.
All efforts were made for bacteriological and/or histologi-
cal confirmation. In patients with clinical and/or radio-
graphic findings suggestive of TB, respiratory samples
consistent of three sputum specimens (or three gastric
washings in the absence of of productive cough) were
stained with Ziehl-Neelsen stain and cultured in Lowen-
stein-Jensen medium for M. tuberculosis. A Bronchoalveo-
laren lavage was also performed for each patient with
negative cultures, but highly suggestive features of TB.
HDPs with Lymphadenitis had superficial or deep lymph
node biopsies. In case of no lymph node extrapulmonary
involvement, TB was identified on the basis of clinical
findings and positive biopsies and cultures from one or
more clinical specimens.
To identify the RR for TB in haemodialysis patients accu-
rately, on a population basis, the Prefecture's Health Serv-
ice registries, where all TB cases diagnosed are mandatory
reported, were also reviewed. From these, the rate of TB,
for the age-matched control group was estimated. Partici-
pants provided informed consent.
Participants
Of the 272 end stage renal disease patients who were
included in the study, 193 were male and 79 female. Their
median age was 52.7 years, ranging from 25 to 77 years.
They were treated with dialysis for a mean of 3.9 years
(range 1 week to 18.4 years). Primary renal disease was
classified in eight categories: glomerulonephritis (48),
nephroangiosclerosis (46), diabetic nephropathy (75),
polycystic kidneys (22), interstitial nephritis-reflux neph-
ropathy or nephritis due to analgesic abuse (42), infection
(15), renal carcinoma (2) and unknown origin (22). Five
patients had a history of active pulmonary TB, but all had
been treated adequately. Close, non-hospital contacts of
persons with infectious TB were reported in seven
patients. As Greece is among the countries where BCG
vaccination is still in use, most patients have been vacci-
nated at the age of six years. However, only 173 patients
remembered or had scars of vaccination with BCG.
Patients on corticosteroids or other immunosuppressive
therapy were not included in this study because of the
rather small number among the patients dialysed in our
units. We did not perform a routine assessment for HIV
infection, as in our area prevalence of HIV associated TB is
insignificant.BMC Nephrology 2009, 10:36 http://www.biomedcentral.com/1471-2369/10/36
Page 3 of 7
(page number not for citation purposes)
Tuberculin Skin Testing (TST)
TST was carried out by the intradermal (Mantoux)
method. It was administered by injecting 0.1 ml of com-
mercially available tuberculin (PPD-Merieux, 5 U/0.1 ml
dose), intradermally into the anterior surface of the fore-
arm, and was read 48-72 hours later. A positive TST was a
skin induration ≥10 mm (5-9 mm weak-positive and 0-4
mm negative). A second booster injection with 10 U/0.1
ml dose, was given within a 10-day interval to those HDPs
responding with a <10 mm induration to the first test. The
pen method was used for the measurement of skin tuber-
culin reaction as previously described [7,8].
Chest Radiography
Entering the study, all patients had a chest X-ray, evalu-
ated by two independent physicians, (radiologist and pul-
monologist). Radiographic findings that could be
attributed to previous healed TB were described as: 1)
Dense pulmonary nodules, with (group-A, n = 51) or
without visible calcification (group-B, n = 36), in the hilar
area or upper lobes, 2) smaller nodules with or without
fibrotic scars in the upper lobes, accompanied with upper-
lobe volume loss (group-C, n = 32) and 3) bronchiectasis
of the upper lobe and/or pleural scarring (group-D, n =
37). Nodules and fibrotic lesions of previous, healed TB
were prescribed as hard-well-demarcated with sharp mar-
gins.
Statistical methods
TB prevalence was defined as the number of TB cases per
a hypothetical population at risk of 100. Analysis of vari-
ance (ANOVA) was used to assess the statistical signifi-
cance of differences. For multivariate analysis, only factors
that were significantly different (P < 0.05) in univariate
comparison were retained. The independent effects of the
significant factors, was determined using a multivariate
analytical method the Cox's proportional hazard model.
[9] Trends in prevalence and risk for TB through the differ-
ent studied factors were assessed by Spearmans's product
moment correlation coefficient (r), a dimensionless index
that ranges from -1.0 to 1.0, reflecting the extent of the
relationship between data sets.
Results
Findings of the tuberculin skin testing
Upon entering the study, the prevalence of a positive TST
was 18.9% for the first and 22.7% (n = 62) for the second
test. Twenty-seven patients (9.9%) demonstrated a weak-
positive response. A negative response to TST was
recorded in 183 HDPs (67.2%). (Table 1)
TB incidence
During the 36 month follow up period, 24 HDPs devel-
oped active TB, a rate of 8.2%. TB incidence was signifi-
cantly higher in diabetics (P = 0.01), increased with
increasing age (r = 0.95, P = 0.006) and tuberculin reactiv-
ity at inclusion (r = 0.84, P = 0.02), while decreased with
increasing BMI (r = -0.98, P < 0.001). (Tables 1 and 2) Sev-
enteen of the HDPs with negative TSTs at inclusion (17/
183) developed active TB. Thirteen of them (13/17) had
negative TSTs even when the active disease developed.
In 4 of the cases (16.6%), lungs were the only site of
involvement. Extra-pulmonary manifestations were veri-
Table 1: The risk for TB in dialysis patients by TST at onset, chest radiography and dialysis stage
Characteristic (%) Population at risk TB cases TB rate RR Adj RR 95% CI
TST at inclusion (mm)
0-4 183 14 7.65 69.5 24.5 22.5-26.5
5-9 27 2 7.40 67.2 8.4 3.1-13.6
≥10 62 8 12.0 109.0 41.4 37.9-44.8
r 0.84 0.51
P value 0.02 0.03
Inactive-TB evidence on chest x-ray
Yes 67 10 14.9 135.4 82.3 51.3-95.5
No 205 14 5.4 49.9 21.3 19.8-22.8
Ratio 0.06 10.8 2.7 3.8
P value  < 0.001  < 0.001
Dialysis stage in months
0-12 67 16 23.82 216.3 110.0 97.4-135.3
13-60 149 3 2.01 18.3 9.3 5.2-14.6
≥60 56 5 8.92 81.0 41.3 31.3-56.8
r -0.46 -0.58
P value  < 0.001  < 0.001
RR: relative risk taking as reference group subjects from the general population, Adj RR: adjusted relative risk after allowing for the effect of the 
other characteristics, CI: Wald 95% Confidence Interval, r: correlation coefficient, P value: for the differences between groupsBMC Nephrology 2009, 10:36 http://www.biomedcentral.com/1471-2369/10/36
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fied in the remaining 20 cases (83.4%), with lymph
nodes, pleural, pericardium, peritoneum, liver, spleen,
kidneys and bones being the sites of involvement
reported.
Association of chest X-ray with TB incidence
From the 67 patients with findings suggestive of old-
healed TB in chest radiographs, upon entering the study,
10 (10/67, 14.9%) developed active TB. Three of them,
with group-B, six with group-C and one with group-D
type of old-healed TB lesions in the chest radiographs. The
rate of TB was: 0, 8.3, 18.7 and 2.7% for A, B, C and D
group respectively. Totally, HDP with old-healed TB
lesions on chest radiographs demonstrated an almost
three-fold higher risk for developing active TB as com-
pared to HDPs without such lesions (14.9% vs  5.4%).
(Table 1)
Lesions were described in: 27 (27/62, 43.5%) patients
with positive, 8 patients (8/27, 29.6%) with weak-positive
and 32 patients (32/183, 17.4%) with negative TST).
Using both TST and chest radiography 102 HDP (37.5%)
were identified as having been infected with M. Tubercu-
losis.
Findings of the univariate analysis
The demographic and other clinical important determi-
nants of those HDPs who developed active TB are pre-
sented in Table 3, in comparison with the characteristics
of those HDP who did not develop TB during the period
of the follow up. The univariate comparison of non TB vs.
TB HDPs, showed no significant differences as to: effi-
ciency of dialysis Kt/V (P = 0.30), URR (P = 0.97), serum
levels of albumin (P = 0.98), serum levels of zinc (0.27),
use of vitamin D supplements (P = 0.66) and BCG vacci-
nation (P = 0.92). There were no cases of TB among HDPs
with previous history for TB (disease or contact). During
the same period, 131 cases of TB were reported to the Pub-
lic Health Services' registry of Achaia. The prevalence of TB
for the age-matched general population was 0.11%.
Findings of the multivariate analysis
Age, BMI, incidence of diabetic nephropathy, chest X-ray
lesions of old healed TB, initial tuberculin sensitivity and
time on dialysis were significantly different factors
retained for multivariate analysis. (Table 3) The estimated
adjusted RRs (Adj.RRs) were appreciably smaller than the
respective RRs, due to the high correlation between the
studied factors. However, even after allowing for the effect
of the other studied factors, the risk for TB remained sig-
nificantly higher in diabetics (P = 0.03)and those patients
with chest radiographs suggestive of old-healed TB (P <
0.001). Furthermore, increasing trends with increasing
age (r = 0.95) and decreasing BMI (r = 0.99, P < 0.001)
were still demonstrated (Tables 1 and 2). The Adj.RR for
the tuberculin skin test result of 0-4 mm group was signif-
Table 2: The risk for TB in dialysis patients, by sex, age, Body Mass Index (BMI) and Diabetes Mellitus.
Characteristic Population at risk TB cases TB rate (%) RR Adj RR 95% CI
Sex
Male 193 15 7.7 70 28.2 26.4-30.1
Female 79 9 11.3 102.7 34.5 31.4-37.5
M:F ratio 2.4 0.6 0.8
P value 0.003 0.01
Age
≤ 49 38 2 5.2 47.8 16.2 11.7-20.6
50-69 165 12 7.2 66.1 22.8 20.6-24.9
≥ 70 69 10 14.4 130.9 25.3 20.4-28.4
r 0.95 0.95
P value 0.006 0.02
BMI
< 18 58 9 15.5 140.9 72.3 65.2-79.8
18-25 79 7 8.8 80.0 36.8 28.3-44.5
25-30 92 6 6.5 59.0 28.4 22.1-34.3
>30 43 2 4.6 42.2 23.1 18.4-28.2
r -0.98 -0.99
P value  < 0.001  < 0.001
Diabetes Mellitus
Yes 75 8 10.6 96.3 25.3 20.4-28.4
No 197 16 8.1 73.6 19.2 17.2-21.1
DM:no DM ratio 0.3 1.3 1.3
P value 0.01 0.03
RR: relative risk taking as reference group subjects from the general population, Adj RR: adjusted relative risk after allowing for the effect of the 
other characteristics, CI: Wald 95% Confidence Interval, r: correlation coefficient, P value: for the differences between groups.BMC Nephrology 2009, 10:36 http://www.biomedcentral.com/1471-2369/10/36
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icantly lower in comparison to the respective value for the
≥10 mm group (P < 0.001). However, the Adj.RR for the
5-9 mm group was significantly lower than the respective
value for the 0-4 mm group (P = 0.002), resulting finally
in a weaker correlation (r = 0.51) between tuberculin sen-
sitivity and the risk for developing TB. (Table 1)
Patients undergoing dialysis for a shorter than 12 months
period were presented with significantly higher risk for
TB, as compared to patients treated for a longer period (P
< 0.001). The lowest risk for TB was recorded in patients
treated with dialysis for 13 to 60 months. However, a sig-
nificant re-increase in the risk for TB was observed in
patients treated for more than 60 months (P < 0.001).
(Table 1)
Discussion
Worldwide TB infection in dialyzed patients ranges from
5-25% and a 6.9-52.5-fold risk of TB is reported as com-
pared to the general population [[3,10,11], and [12]].
These findings were verified in our study too. The absence
of significant differences in Mantoux positivity and/or the
incidence of active TB among the three medical centres
involved in our study and the high incidence of extra pul-
monary forms minimized the impact of clustering and/or
the possibility of nosocomial spread.
Advanced age, diabetes mellitus and low BMI, are known
factors of immunological imbalance, associated with TB
development in the general population. In HDPs they
have been also associated with depressed cell-mediated
immune responses and anergy [6,13-17]. In our study,
they were proved to be factors predisposing to active TB
development in haemodialysis patients too. That is why
they have to be considered evaluating for TB in the dialysis
settings. Their existence supports the decision to prevent
or even to treat when definitive diagnosis of clinical man-
ifested TB is not possible, although there is strong pre-
sumptive evidence.
Most authors agree that to provide substantial protection
against TB in HDPs, chemoprophylaxis should be com-
menced in all patients with a positive TST [5]. In the gen-
eral population, TST remains the most satisfactory tool for
diagnosing TB infection, and initial tuberculin sensitivity
was well associated with the incidence of TB [18]. Boosted
TSTs are usually recommended for immunocompromised
patients like HDPs [19,27]. Most authors agree that in the
hemodialysis population two consecutive tests (within to
a 7-14 days interval) with a higher strength (usually dou-
ble) purified protein derivative, are sufficient to rule out
the booster effect, maximizing the identification of the
infected patients [20-22]. However, in the current study,
HDPs presented a weaker association between initial
tuberculin sensitivity and the subsequent risk for TB. A
substantial proportion of the HDPs that developed TB,
had negative TSTs upon entering the study (14/24) and/or
when the active disease was developed (8/24). As anergy
distorted tuberculin reactivity, TST underestimated the
incidence of TB infection among our patients [6,23].
Table 3: Comparison of the baseline characteristics of the dialysis patients who developed/or not TB.
Characteristic non TB Dps TB Dps P values
Number 248 24
Mean age (years) 50.8 (27-75) 61.5 (16-77) 0.03
Sex (male: female ratio) 2.5 0.6 < 0.001
Time on dialysis (years) 3.9 (0.12-18.6) 2.2(0.06-17.8) 0.01
Kt/V 1.49 (1.33-1.67) 1.51 (1.35-1.71) 0.30
URR 71(61-77) 72(61-77) 0.97
Response to tuberculin (mm) 4.21(0-12) 7.16 (0-20) < 0.001
Body mass index 23 (12-28) 15 (14-32) < 0.001
Vitamin D (no/yes) 83 10 0.66
Users: no users ratio 0.33 0.4
Albumin (g/l) 35.2 (33-37.35) 32 (33.2-37) 0.98
Zinc (μg/dl) 77 (69-86) 75 (68.75-83) 0.27
Diabetics (DM) 67 8 0.04
DM: non DM ratio 0.2 0.3
Old TB evidence on x-Ray 51 16
abnormal: normal x-Ray ratio 0.2 0.6 < 0.001
Previous TB disease 5 0
Previous TB contact 7 0
BCG vaccination 167 15 0.92
Vaccinated: non vaccinated ratio 0.67 0.62BMC Nephrology 2009, 10:36 http://www.biomedcentral.com/1471-2369/10/36
Page 6 of 7
(page number not for citation purposes)
Unlike the TST, measurement of PPD reactivity by in vitro
quantification of PPD-specific T cells has been reported
unaffected by uremia-associated immunosuppression
[24]. Nowadays, using a rapid 6-hour assay we can enu-
merate peripheral blood-derived interferon-γ secreting T
cells responding to epitopes from an early secretory anti-
genic target-6 (ESAT-6) that is highly specific for M. Tuber-
culosis complex but absent from M. Bovis bacillus Calmete-
Guerin (BCG) vaccine strains. Such whole-blood assays
may thus be valuable alternative to skin testing in no
endemic regions, but they are not still available for the
National Health System of Greece [25,26].
Obviously in HDPs, a negative TST has a comparatively
low prognostic and diagnostic importance. However, as
HDPs with positive TSTs presented increased risk for
developing TB, a positive TST should never be underesti-
mated.
Persons with abnormalities on chest radiographs consist-
ent with prior, healed TB have a high risk for progression
to active TB (2.0-13.6 per 1000 person-years of observa-
tion). Nodules and fibrotic changes may contain slowly
multiplying tubercle bacilli with substantial potential for
future progression to active TB [27]. HPDs with radio-
graphic evidences of healed TB, demonstrated an almost
4-fold higher risk of developing active TB, independently
of the result of the TST, even after allowing for the effect
of the remaining risk factors. In our study the radiographic
lesions were categorized and the specific significance of
their appearance was assessed. Patients with non-calcified
nodules and fibrotic changes in the upper lobes of the
lungs, presented with the highest risk of TB. Bronchiecta-
sis and pleural scarring are nonspecific findings that
sometimes occur from previous pulmonary TB, but are
more commonly caused by trauma or other infections.
Conversely, calcified nodular lesions (calcified granulo-
mas) and apical or basal pleural thickening posed a lower
risk for future progression to active TB. In the case of
HDPs such lesions may also represent metastatic calcifica-
tions attributed to the secondary hyperparathyroidism, a
common clinical situation in uremic patients [28].
The weak correlation between chest radiography and TST
positivity recorded in our, as well as in previous studies,
verifies the value of chest X-ray in detecting TB infection
in haemodialysis patients [29]. Commencing chemo-
prophylaxis in all HDPs with evidences of healed TB on
chest X-rays, especially when diabetic nephropathy is an
issue and/or when HDPs are malnourished and they have
not been treated adequately in the past, regardless of their
response to TST, will improve the control and prevention
of TB in this high risk population.
An additional issue, investigated in our study, was the
appropriate time for screening with TST and eventually
commencing TB chemoprophylaxis in HDPs. There was a
significantly higher prevalence and risk for TB recorded, in
those patients dialysed for a shorter than a 12 month
period. A result well associated with the depressed cell-
mediated immune responses recorded in HDPs during an
early dialysis stage [6]. It is important to notice that 16 out
of the 24 TB cases developed before the first 12 months
elapsed since undergoing dialysis, a finding verified in
previous studies too [2,30].
In our study, several unresolved issues concerning the
identifications of those HDPs who would benefit with TB
chemoprophylaxis, were investigated. Calcitriol, which is
supposed to restore partly the lymphocyte function and
low zinc levels that had been associated with higher
anergy [13,14] were not correlated with the development
of TB. The efficiency of dialysis didn't influence the risk for
TB either.
Conclusion
The above observations allow us to propose that in order
to provide substantial protection against TB in HDPs, the
annual skin testing which is recommended, has to be
changed to testing upon admission to a regular dialysis
program. HDPs with a positive TST and/or lesions sugges-
tive of old healed TB in a recent chest X-ray are candidates
for preventive therapy. As diabetic nephropathy and/or
low BMI were proved to be independed factors of TB
development, their existence supports also the decision to
treat. Exception should be made for the elderly HDPs as
they are more prone to the pharmacological toxicity of
isoniazid [31]. However, as advanced age (> 65 years old)
is an independed factor predisposing to TB, the need for a
high index of suspicion and timely diagnostic work up
should be reinforced in this group of HDPs. Tuberculin
skin test and chest radiography upon entering a chronic
dialysis program will provide a baseline with which to
compare subsequent tests.
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